Entasis Therapeutics Holdings Inc.
ETTX
ETTX was delisted on the 8th of July, 2022.
25 hedge funds and large institutions have $9.34M invested in Entasis Therapeutics Holdings Inc. in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 5 reducing their positions, and 4 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 5
0% more funds holding
Funds holding: 25 → 25 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
15% less capital invested
Capital invested by funds: $11.1M → $9.34M (-$1.71M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$796K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$205K |
| 3 |
Squarepoint
New York
|
+$91.2K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$74.9K |
| 5 |
Two Sigma Investments
New York
|
+$52.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$821K |
| 2 |
VF
Virtu Financial
New York
|
-$361K |
| 3 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$229K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$215K |
| 5 |
Millennium Management
New York
|
-$122K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
UBS Group
Zurich,
Switzerland
| – | -$1K | -364 | Closed |
|
27
Bank of America
Charlotte,
North Carolina
| – | +$131 | +46 | New |
|
28
Barclays
London,
United Kingdom
| – | +$318 | +112 | New |
|
ETTX Hedge Fund Activity: Q1 2021 in Review
25 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Entasis Therapeutics Holdings Inc. (ETTX) for Q1 2021, worth a combined $9.34M — down 15% from $11.1M a quarter earlier.
Fund positioning in ETTX was balanced in Q1 2021: 4 funds opened new positions, 4 closed out, 11 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $796K. The largest seller was Eventide Asset Management, cutting an estimated $821K.
- 25 institutional investors held Entasis Therapeutics Holdings Inc. (ETTX) as of Q1 2021, unchanged from Q4 2020.
- Funds reported $9.34M of Entasis Therapeutics Holdings Inc. stock for Q1 2021, down 15% quarter-over-quarter.
- 4 funds opened new Entasis Therapeutics Holdings Inc. positions in Q1 2021 and 4 closed out, a net change of 0 holders.
- The largest Entasis Therapeutics Holdings Inc. buyer in Q1 2021 was Renaissance Technologies, an estimated $796K added.
- The largest Entasis Therapeutics Holdings Inc. seller in Q1 2021 was Eventide Asset Management, an estimated $821K sold.
Based on aggregated 13F filings for Q1 2021.